Search Results 1-10 of 16439 for Huntington's+disease

  1. Huntington's disease - Symptoms and causes - Mayo Clinic

    This rare disease causes an early decay of nerve cells in the brain. Learn about its symptoms and how treatments may help.

  2. Huntington's disease - Diagnosis and treatment - Mayo Clinic

    Diagnosis · Neurological exam · Neuropsychological testing · Mental health evaluation · Brain-imaging and function tests · Genetic counseling and testing · Predictive ...

  3. Parkinson's disease - Diagnosis and treatment - Mayo Clinic

    This test, also called an alpha-synuclein seed amplification assay, detects Parkinson's disease before symptoms begin. Alpha-synuclein clumps are a hallmark ...

  4. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  5. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

  6. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  7. Huntington's disease - Care at Mayo Clinic

    Advanced diagnosis and treatment. Mayo Clinic doctors have expertise and experience in evaluating and treating people with Huntington's disease and other ...

  8. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...

  9. Hematology - Clinical trials

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  10. A Study to Investigate the Long Term Safety, Tolerability And Effectiveness of Pf-02545920 in Subjects with Huntington's Disease Who Completed Study A8241021 - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...